Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Bipolar disorder is a ...

In addition to offering diabetes management and weight loss benefits, a national cohort study published in Acta Psychiatrica ...

People living with treatment-resistant bipolar disorder still have options to manage their condition. However, the choices ...

A watchdog scorecard found that 49% of hospitals fully comply with federal price rules, up from 21%. Only 18% post real dollar prices broadly. Native Americans and Alaska Natives are exempt from ...

Medications are often the first-line treatment approach for bipolar disorder. Drug interventions are most effective when combined with psychotherapy, such as cognitive behavioral therapy or ...

Postpartum psychosis is a rare, clinically dramatic disorder typically beginning within a few weeks of delivery. Recent ...

An antipsychotic approved by the FDA in 2009 to treat schizophrenia has now been green-lighted for use in bipolar 1 disorder. Iloperidone (Fanapt) is now FDA-approved for adults with bipolar 1 ...

If you or a loved one has bipolar disorder, you may be exploring treatment options to help manage symptoms. Bipolar disorder is a mental health condition that causes changes in mood, energy, and ...

DelveInsight's 'Bipolar Disorder Pipeline Insight 2025' report provides comprehensive global coverage of pipeline therapies for bipolar disorder across various stages of clinical development. The ...

"With bipolar medications, some are fast-acting and can take effect in a matter of hours or days," says Naomi Torres-Mackie, PhD, a clinical psychologist at Northwell Health’s Lenox Hill Hospital in ...

We specialize in providing care for adults dealing with complex behavioral health diagnoses, offering in-person care for conditions such as: anxiety, schizophrenia, schizoaffective disorder, suicidal ...

Hayes et al 12 conducted one of the most recent large studies to compare lithium with newer second-generation antipsychotics as maintenance monotherapy for bipolar disorder. The authors concluded that ...